The conference call will take place at
The conference call also will be webcast live over the Internet and can
be accessed on the "Investors" section of the Cerulean website, www.ceruleanrx.com.
The webcast will be archived on the Company's website until
About Daré Bioscience
Daré Bioscience is a clinical-stage pharmaceutical company focusing on the development and commercialization of products for women's reproductive health. Daré is committed to advancing novel clinical-stage candidates in women's reproductive health to expand options and improve outcomes. Product development in women's reproductive health is fragmented creating a potential opportunity for Daré. Our goal is to fill the gap by taking products from innovation through development - the Daré team is well-suited to ensure these products advance and are one day commercially available. The founders bring experience in global women's healthcare as well as success in prior ventures in funding, achieving regulatory approvals, partnering, and launching a number of products, including devices, therapeutics and diagnostics. For more information on the company, please visit www.darebioscience.com.
Cerulean is a company focused on applying the Dynamic Tumor Targeting™ Platform to create nanoparticle-drug conjugates (NDCs) designed to selectively attack tumor cells, reduce toxicity by sparing the body's normal cells, and enable therapeutic combinations.
Additional Information about the Proposed Transaction and Where to Find It
In connection with the proposed Daré transaction, Cerulean intends to
file relevant materials with the
Participants in the Solicitation
Cerulean, Daré, and each of their respective directors and executive
officers may be deemed to be participants in the solicitation of proxies
from the stockholders of Cerulean in connection with the proposed
transaction described herein. Information regarding the interests of
these directors and executive officers in the proposed transaction
described herein will be included in the Proxy Statement described above.
Additional information regarding the directors and executive
officers of Cerulean is included in proxy statement for its 2016 Annual
Meeting, which was filed with the
News Provided by Acquire Media